Name: Eli Lilly licenses Peptron’s SmartDepot by October 7?
Start: 2026-05-06T00:05:15.953Z
End: 2026-10-07T14:59:00.000Z

Question 1

How do prediction market odds compare to analyst forecasts?

Accepted Answer

Currently, prediction market odds reflect a different perspective than many traditional analyst forecasts regarding the Eli Lilly licensing deal. While some analysts believe a deal is likely, given the potential benefits of SmartDepot, the market suggests a lower probability of completion. This discrepancy could be due to factors not fully captured in traditional analysis, such as confidential negotiations or unforeseen regulatory hurdles. It's important to remember that this market represents the collective wisdom of traders willing to put capital behind their beliefs, offering a unique signal compared to expert opinions.

Question 2

How is this market priced on Polymarket?

Accepted Answer

On Polymarket, this market is priced through a continuous auction mechanism, where traders buy and sell contracts representing their belief in the outcome. The price of a contract directly reflects the probability of the event occurring, as perceived by the market participants. On Polymarket, prices reflect that venue's order book, liquidity, and how traders price the outcome right now. The more traders believe the deal will happen, the higher the price of the 'yes' contract will climb, and vice versa. This dynamic pricing ensures that the market odds constantly adapt to new information and changing sentiment surrounding the Eli Lilly licensing deal.

Question 3

When does this market resolve, and what determines the outcome?

Accepted Answer

This market resolves around Oct 7, 2026, with the outcome confirmed once the event is verifiable from credible public reporting. Specifically, the resolution will depend on whether Eli Lilly publicly announces a licensing agreement for Peptron’s SmartDepot before the resolution date. Any official press releases, SEC filings, or announcements from either company will be considered as evidence. The outcome will be determined based on publicly available information and will not rely on any subjective interpretation or internal data.

Question 4

What signals or events could move this market between now and resolution?

Accepted Answer

Several signals or events could significantly impact this market. Any news regarding the status of negotiations between Eli Lilly and Peptron, such as reports of progress or roadblocks, would likely cause price movement. Positive clinical trial data for SmartDepot could increase the perceived value of the asset and boost the 'yes' side of the market. Conversely, negative news, such as regulatory concerns or competing offers, could push the odds lower. A formal announcement of a different licensing agreement by Eli Lilly could also have a substantial effect on this market.

Eli Lilly licenses Peptron’s SmartDepot by October 7?

Markets

Details